Sunshine Biopharma, Inc.
SBFM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$5,134 | -$4,506 | -$26,744 | -$12,436 |
| Dep. & Amort. | $224 | $149 | $25 | $13 |
| Deferred Tax | $0 | $0 | $4 | -$918 |
| Stock-Based Comp. | $0 | $0 | $0 | $918 |
| Change in WC | -$5,381 | -$4,418 | $3,155 | -$109 |
| Other Non-Cash | -$2,240 | $0 | $18,316 | $10,703 |
| Operating Cash Flow | -$12,531 | -$8,775 | -$5,248 | -$1,829 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2,321 | -$82 | -$305 | $0 |
| Net Acquisitions | $0 | $0 | -$14,348 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$574 | $33 | $0 |
| Investing Cash Flow | -$2,321 | -$656 | -$14,619 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $348 | -$126 | -$1,932 | $2,905 |
| Stock Issued | $8,522 | $4,089 | $30,367 | $0 |
| Stock Repurch. | -$3,140 | -$541 | -$99 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $3,559 | $7 | $11,129 | $0 |
| Financing Cash Flow | $9,290 | $3,426 | $39,465 | $2,905 |
| Forex Effect | -$1,043 | $472 | $184 | -$20 |
| Net Chg. in Cash | -$6,606 | -$5,534 | $19,781 | $1,055 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $16,292 | $21,826 | $2,045 | $990 |
| End Cash | $9,687 | $16,292 | $21,826 | $2,045 |
| Free Cash Flow | -$14,852 | -$9,563 | -$5,553 | -$1,829 |